GSK Quick Ratio 2010-2022 | GSK
Historical quick ratio values for GSK (GSK) over the last 10 years.
| GSK Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-12-31 |
$19.32B |
$28.21B |
0.69 |
| 2022-09-30 |
$18.36B |
$24.68B |
0.74 |
| 2022-06-30 |
$62.18B |
$47.50B |
1.31 |
| 2022-03-31 |
$30.84B |
$32.58B |
0.95 |
| 2021-12-31 |
$17.73B |
$32.55B |
0.55 |
| 2021-09-30 |
$16.56B |
$30.91B |
0.54 |
| 2021-06-30 |
$15.71B |
$29.90B |
0.53 |
| 2021-03-31 |
$16.97B |
$27.96B |
0.61 |
| 2020-12-31 |
$18.30B |
$28.44B |
0.64 |
| 2020-09-30 |
$17.36B |
$28.65B |
0.61 |
| 2020-06-30 |
$20.58B |
$29.69B |
0.69 |
| 2020-03-31 |
$20.59B |
$32.45B |
0.63 |
| 2019-12-31 |
$17.29B |
$30.71B |
0.56 |
| 2019-09-30 |
$17.53B |
$31.46B |
0.56 |
| 2019-06-30 |
$15.77B |
$33.14B |
0.48 |
| 2019-03-31 |
$15.43B |
$31.86B |
0.48 |
| 2018-12-31 |
$15.29B |
$30.02B |
0.51 |
| 2018-09-30 |
$15.15B |
$23.97B |
0.63 |
| 2018-06-30 |
$15.11B |
$24.77B |
0.61 |
| 2018-03-31 |
$14.98B |
$37.47B |
0.40 |
| 2017-12-31 |
$13.34B |
$34.24B |
0.39 |
| 2017-09-30 |
$15.70B |
$35.92B |
0.44 |
| 2017-06-30 |
$13.66B |
$36.81B |
0.37 |
| 2017-03-31 |
$14.08B |
$23.23B |
0.61 |
| 2016-12-31 |
$15.73B |
$25.75B |
0.61 |
| 2016-09-30 |
$16.07B |
$23.82B |
0.68 |
| 2016-06-30 |
$16.34B |
$25.98B |
0.63 |
| 2016-03-31 |
$15.32B |
$19.94B |
0.77 |
| 2015-12-31 |
$18.15B |
$20.52B |
0.89 |
| 2015-09-30 |
$18.80B |
$19.77B |
0.95 |
| 2015-06-30 |
$20.40B |
$21.13B |
0.97 |
| 2015-03-31 |
$24.69B |
$23.93B |
1.03 |
| 2014-12-31 |
$17.22B |
$21.91B |
0.79 |
| 2014-09-30 |
$17.69B |
$25.52B |
0.69 |
| 2014-06-30 |
$15.89B |
$20.62B |
0.77 |
| 2014-03-31 |
$15.15B |
$19.31B |
0.78 |
| 2013-12-31 |
$17.72B |
$21.40B |
0.83 |
| 2013-09-30 |
$14.42B |
$19.89B |
0.73 |
| 2013-06-30 |
$14.28B |
$19.17B |
0.75 |
| 2013-03-31 |
$15.41B |
$18.66B |
0.83 |
| 2012-12-31 |
$15.41B |
$21.90B |
0.70 |
| 2012-09-30 |
$14.94B |
$22.06B |
0.68 |
| 2012-06-30 |
$21.07B |
$24.39B |
0.86 |
| 2012-03-31 |
$19.28B |
$22.83B |
0.84 |
| 2011-12-31 |
$19.72B |
$24.08B |
0.82 |
| 2011-09-30 |
$19.92B |
$21.13B |
0.94 |
| 2011-06-30 |
$19.65B |
$22.23B |
0.88 |
| 2011-03-31 |
$20.44B |
$20.99B |
0.97 |
| 2010-12-31 |
$18.86B |
$19.51B |
0.97 |
| 2010-09-30 |
$19.71B |
$17.42B |
1.13 |
| 2010-06-30 |
$19.41B |
$17.91B |
1.08 |
| 2010-03-31 |
$22.17B |
$18.98B |
1.17 |
| 2009-12-31 |
$21.15B |
$18.98B |
1.12 |
| 2009-09-30 |
$21.58B |
$18.26B |
1.18 |
| 2009-06-30 |
$17.56B |
$13.99B |
1.26 |
| 2009-03-31 |
$18.49B |
$14.02B |
1.32 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$75.923B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
